HDAC9 and neoplasm: These results indicate that HDAC inhibitors and ATRA reactivate RARβ2 via histone modification and sequentially upregulate other TSGs, thereby restoring the function of key regulatory pathways for cell differentiation and apoptosis, which contribute to the inhibition of tumor xenografts.